"Om Research partners with local physicians to conduct clinical trials to find out if a new or FDA approved test, device or drug is safe and effective. Volunteers participate in a clinical trial and play a major role in the development of new drugs that may help them and others like them. Those who participate will not be charged for study medications or study related visits and procedures. Also, volunteers may receive compensation for reasonable travel expenses. Medical insurance is not required."

During the past decade, Om Research LLC conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 23 clinical trials were completed, i.e. on average, 36.5% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 23 clinical trials were completed. i.e. 57.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Om Research LLC" #1 sponsor was "Celgene" with 8 trials, followed by "Janssen Research & Development, LLC" with 8 trials sponsored, "Pfizer" with 5 trials sponsored, "Shire" with 5 trials sponsored and "Allergan" with 5 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Om Research LLC" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 4 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator and "The Emmes Company, LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Om Research LLC" are "Ulcerative Colitis" (17 trials), "Crohn's Disease" (8 trials), "Crohn Disease" (5 trials), "Gastroparesis" (4 trials) and "Colitis, Ulcerative" (3 trials). Many other conditions were trialed in "Om Research LLC" in a lesser frequency.

Most popular intervention types in "Om Research LLC" are "Drug" (59 trials), "Other" (13 trials), "Biological" (4 trials), "Combination Product" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (44 trials), "Etrasimod" (6 trials), "Guselkumab" (4 trials), "Ontamalimab" (4 trials) and "Ozanimod" (4 trials). Other intervention names were less common.

The vast majority of trials in "Om Research LLC" are 63 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Om Research LLC". undefined are not yet recruiting, 25 are recruiting, 13 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 12 completed trials in Om Research LLC, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Om Research LLC, 2 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".